title: Observed patient compliance with a structured outpatient bladder retraining program.
abstract: OBJECTIVE
  Our purpose was to determine patient compliance with a telephone-based retraining program.
  
  
  METHODS
  This was a retrospective study of 123 women with urinary urgency or urge incontinence who were offered bladder retraining with facsimile machine submission of a retraining diary and weekly telephone feedback.
  
  
  RESULTS
  Completion was defined as having >/=4 follow-up sessions and >/=6 weeks of retraining. Seventy-one percent (87/123) began the retraining program; 63% (55/87) of them completed it, for an overall compliance rate of 45% (55/123). When we compared those who completed retraining with those who started but did not complete it, only concurrent use of pharmacologic therapy was significantly different (87% vs 53%, respectively; P <.001). This difference remained significant after we controlled for other independent variables, including urodynamic diagnosis and physician.
  
  
  CONCLUSIONS
  A total of 55% of women to whom telephone-based bladder retraining was recommended either never started or were noncompliant with the treatment. Bladder retraining success in the "real world" may be substantially lower than that described in well-funded labor-intensive clinical trials.
authors.affiliation: Division of Gynecologic Specialties, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710, USA. visco001@mc.duke.edu
authors.forename: A G
authors.initials: AG
authors.lastname: Visco
authors.forename: A C
authors.initials: AC
authors.lastname: Weidner
authors.forename: G W
authors.initials: GW
authors.lastname: Cundiff
authors.forename: R C
authors.initials: RC
authors.lastname: Bump
mesh_terms: D000277:Adjuvants, Pharmaceutic; D000553:Ambulatory Care; D001521:Behavior Therapy / Q000379:methods; D005260:Female; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D010353:Patient Education as Topic / Q000379:methods; D012189:Retrospective Studies; D013689:Telephone; D014549:Urinary Incontinence / Q000628:therapy*; D014563:Urodynamics
chemical_list: D000277:Adjuvants, Pharmaceutic